CLINUVEL to advance novel pharmaceutical formulations in preclinical program
Go back to CLINUVEL to advance novel pharmaceutical formulations in preclinical program| Clinuvel Pharmaceuticals Ltd Sponsored ADR (AMEX: CLVLY) | Delayed: 7.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.36 | 52 Week High | $6.92 | |||
| Open | $7.36 | 52 Week Low | $1.79 | |||
| Day High | $7.36 | P/E | N/A | |||
| Day Low | $7.36 | EPS | $0.00 | |||
| Volume | 1 | |||||
| PC Universe, Inc. New (AMEX: CUV) | Delayed: 0.15 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.15 | 52 Week High | $0.15 | |||
| Open | $0.15 | 52 Week Low | $0.15 | |||
| Day High | $0.15 | P/E | N/A | |||
| Day Low | $0.15 | EPS | $0.00 | |||
| Volume | 0 | |||||
